Vanguard Group Inc Lexaria Bioscience Corp. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 127,871 shares of LEXX stock, worth $117,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,871
Previous 127,433
0.34%
Holding current value
$117,641
Previous $268,000
18.66%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LEXX
# of Institutions
24Shares Held
1.28MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA550KShares$505,9510.05% of portfolio
-
Geode Capital Management, LLC Boston, MA172KShares$158,6600.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6130KShares$119,6230.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL61.3KShares$56,3500.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL44.9KShares$41,3080.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $5.47M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...